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Abstract
Background: Many animal experimental studies have been performed to investigate the efficacy of acupuncture in
Parkinson’s disease (PD). Sex differences are a major issue in all diseases including PD. However, to our knowledge,
there have been no reviews investigating sex differences on the effectiveness of acupuncture treatment for animal
PD models. The current study aimed to summarize and analyze past studies in order to evaluate these possible
differences.
Method: Each of 7 databases (MEDLINE, EMBASE, the Cochrane Library, 3 Korean medical databases, and the China
National Knowledge Infrastructure) was searched from its inception through March 2015 without language
restrictions.
Results: We included studies of the use of acupuncture treatment in animal models of PD. A total of 810
potentially relevant articles were identified, 57 of which met our inclusion criteria. C57/BL6 mice were used most
frequently (42 %) in animal PD models. Most of the studies were carried out using only male animals (67 %); only 1
study (2 %) was performed using solely females. The further 31 % of the studies used a male/female mix or did not
specify the sex.
Conclusions: The results of our review suggest that acupuncture is an effective treatment for animal PD models,
but there is insufficient evidence to determine whether sex differences exist. Future studies of acupuncture
treatment for PD should use female animal models because they reflect the physiological characteristics of both
males and females to fully evaluate the effect and the safety of the treatment for each sex.
Keywords: Electro-acupuncture, Manual acupuncture, Bee-venom acupuncture, C57/BL6, Acupuncture point
Background
Parkinson’s disease (PD) is a progressive neurodegenera-
tive disease caused by the loss of dopaminergic neurons
in the substantia nigra [1]. PD usually occurs in individ-
uals over 50 years of age, and its incidence and
prevalence increases among individuals approximately
60 years of age and older. PD has become more com-
mon due to the rapid aging of human populations
around the world [2]. Epidemiological studies have
reported that the incidence of PD is 1.5–2 times higher
in men than in women, and the onset of symptoms may
occur later in women due to the neuroprotective effects
of estrogen [3]. For the disease manifestations of PD,
women have higher Unified Parkinson’s Disease Rating
Scale (UPDRS) motor scores, but present with dyskinesia,
tremor, and PD-related complications more often than
men [4].
Because the FDA reported that eight out of ten new
drugs that had been sold on the market were discon-
tinued because they resulted in far more detrimental
side effects in women, the sex perspective began to
be discussed in many other fields as well [5]. Adverse
drug reactions can be caused by the physiological dif-
ference between men and women, and women can be
* Correspondence: lims@khu.ac.kr
1Department of Applied Korean Medicine, Graduate School, Kyung Hee
University, Seoul, Republic of Korea
2Research Group of Pain and Neuroscience, WHO Collaborating Center for
Traditional Medicine, East–west Medical Research Institute, Kyung Hee
University, Seoul, Republic of Korea
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lee et al. BMC Complementary and Alternative Medicine  (2016) 16:430 
DOI 10.1186/s12906-016-1405-5
more vulnerable to a particular drug [6]. Because sex
is often not considered an important variable in ani-
mal research with the exception of research related to
features of a particular sex, such as reproduction and
endocrine secretion, the overwhelming majority of ex-
perimental research uses only males and many studies
do not even disclose the sex of the experimental ani-
mals. Basic research studies using cells in culture also
often fail to present the sex of the organism from
which the cell strain originated, but the results of
such basic research has been applied generally to
humans. Because medical research studies are per-
formed primarily by male researchers [7–9], the re-
search subjects are also mostly males [10–12], and
there has been a tendency to be careless of females
[13], which can aggravate treatment problems related
to the physiological differences between men and
women. The National Institutes of Health (NIH)
requires applicants to report their cell and animal in-
clusion plans as part of the preclinical experimental
design [14]. Therefore, studies are being performed to
determine what sex differences need to be accounted
for in preclinical and clinical stages, and the import-
ance of the applying these principles is being
highlighted [15].
PD treatment options include pharmacological treat-
ment, non-pharmacological treatment, surgical therapy,
and dopaminergic cell transplantation [15]. Acupuncture
has long been employed for numerous disorders, and it
has been traditionally used to relieve PD-related symp-
toms and to delay the clinical progression of PD symp-
toms [16]. We have reported that acupuncture exerts
increased neuroprotective effects in regions including
the substantia nigra, caudate, thalamus, and putamen in
animal models of PD [17–20]. Acupuncture was also
found to inhibit microglial activation, inflammation, and
iron-related oxidative damage in PD [21].
Sex differences have emerged recently as an important
issue, but sufficient efficacy tests for sex differences in
acupuncture, as in preclinical studies for drug develop-
ment, have not yet been performed. It is necessary to
clarify efficacy differences according to sex in order to
more effectively utilize acupuncture in clinical practice.
Therefore, we carried out the present study to identify
whether adequate research has been conducted so far to
determine the sex differences in the efficacy of acupunc-
ture. Specifically, we analyzed past studies of acupunc-
ture treatment conducted in animal PD models, and
determined whether the body of data was sufficient to
determine the effects of sex differences on the effective-
ness of acupuncture treatment. This review provides the
basis for establishing whether future animal model stud-
ies are necessary to determine possible sex-related differ-
ences in the efficacy of acupuncture for PD.
Methods
Search methods for the identification of studies
The search was performed without restrictions on lan-
guage or year of publication. We searched Medline,
EMBASE, and the Cochrane Central Register of Con-
trolled Trials from the inception of each database through
March 2015. For Korean publications, we searched three
Korean medical databases (Research Information Service
System, National Discovery for Science Leaders, and
OASIS). For Chinese articles, we searched the China
National Knowledge Infrastructure. The keywords used
for the search were the following: “Parkinson’s disease”
OR “Parkinson” AND “acupuncture” OR “acupoints” OR
“electroacupuncture” OR “electro-acupuncture” OR “aur-
iculotherapy” OR “auriculoacupuncture” OR “bee venom
acupuncture” in each database language. The search strat-
egy was adjusted for each database.
Inclusion/exclusion criteria
We included studies of the use of acupuncture treatment
in animal PD models. Trials were excluded if the study
designs did not evaluate the effectiveness of acupuncture
in animal PD models, or if they reported insufficient
data. No search restrictions on language or publication
forms were imposed. During the first stage of selection/
exclusion, titles and abstracts were analyzed, and litera-
ture that had no relevance to our study was excluded.
The second stage of selection/exclusion involved analyz-
ing the full text of particular studies, because it was im-
possible to determine the relevance of the studies based
solely on the abstracts.
Data extraction
Two reviewers (LSH and KJY) independently reviewed
the data extracted from each article using a standardized
data extraction form and reached consensus on all items.
The extracted data included the type of animal PD
models, the sex of the animal PD models, the methods
used to induce PD, the types of acupuncture, the acu-
puncture points, and the effectiveness of the treatment.
Results
Study description
We identified 810 publications, 57 of which met the eli-
gibility criteria (Fig. 1). The 57 articles were published
from 1996 to 2014. The characteristics of the studies are
summarized in Table 1 [7–12, 18, 19, 21–69].
Animals of PD models
The animals of PD models included mice (C57/BL6 and
ICR) and rats (Sprague–Dawley, and Wistar) (Fig. 2).
The most frequently used animal PD model was C57/
BL6, which was used in 24 articles, followed by SD and
Wistar, each of which were used in 15 articles, and ICR
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and undefined animals, which were used in one article
each. All of the studies using C57/BL6 animals used only
males. Of the studies using SD animals, ten used males
only, four used a male/female mix, and one used animals
with undefined sex. Of the studies using Wistar animals,
nine used a male/female mix, two used males only, three
used animals with undefined sex, and one study used
females only.
Methods used to induce PD
The drugs 6-hydroxydopamine (6-OHDA), 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP), and rotenone,
as well as medial forebrain bundle (MFB) transection,
were used to induce PD in the animal models (Fig. 3). 6-
OHDA was used in 47 % (27) of the studies, MPTP was
used in 44 % (25) of the studies, and rotenone was used in
7 % (4) of the studies. MFB transection was used in 2 %
(1) of the studies. Of the studies using 6-OHDA, 13 used
a male/female mix, nine used only males, and five used
animals with undefined sex. All of the studies using MPTP
or Rotenone used only male animals. The study using
MFB transection used only females. Therefore, three out
of the four PD induction models studied were only used
in animals of a single sex. Only the results of 6-OHDA in-
duced animal PD models could potentially be compared
between the sexes.
Types of acupuncture
Electro-acupuncture (EA) was used in 54 % (38) of the
studies, manual acupuncture (MA) was used in 30 %
(18) of the studies, and bee-venom (BV) acupuncture
was used in 11 % (6) of the studies. Of the studies using
EA, 18 used only males, 11 used a male/female mix,
three used animals of undefined sex, and one used only
females. Of the studies using MA, 14 used only males,
two used a male/female mix, and two used animals with
undefined sex. All of the studies using BV acupuncture
used only males (Fig. 4).
Acupuncture points
Regardless of the type of acupuncture, the acupuncture
points used consisted mainly of LR3, GB34, GV20,
GV16, and ST36 (Additional file 1). LR3 was used in
35 % (20) of the studies, and GV34 and GV20 were each
used in 26 % (16) of the studies. Of the studies using
LR3, 14 used only males, three used a male/female mix,
and three used animals with undefined sex. Of the stud-
ies using GB34, 14 used only males, and two used a
male/female mix. Of the studies using GV20, eight used
only males, seven used a male/female mix, and one used
animals with undefined sex. Of the studies using GV16,
seven used only males, three used a male/female mix,
and three used animals with undefined sex. Of the stud-
ies using ST36, four used only males, two used animals
with undefined sex, and one used a male/female mix.
Behavioral test
Behavioral analyses were carried out using the rotational
behavior test, the pole-climbing test, the swimming test,
and locomotor counts (Additional file 2). The rotational
behavior test was used in 56 % (10) of the studies, the
pole-climbing test was used in 22 % (6) of the studies,
and the swimming test, and locomotor counts were each
used in 6 % (1) of the studies. The rotational behavior
Fig. 1 Flowchart of the study selection process
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Table 1 Summary of acupuncture for animal PD models
First author (year) Type of animal
PD models
Sex of animal
PD models
Drugs used to
induce PD
Types of
acupuncture
Types of acupuncture
points
Evaluation of the treatment effectiveness
Bai (2014a) [22] Undefined Undefined 6-OHDA EA GV20, EX-HN5 DA
Bai (2014b) [8] Undefined Male 6-OHDA EA GV20, EX-HN5 Caspase-3
Feng (2014) [10] C57BL/6 Male MPTP MA Undefined Pole-climbing test, BDNF, TH, DA
Yeo (2013) [19] C57BL/6 Male MPTP MA GB34, LR3 TH, gene expression
Alvarez-Fischer (2013) [7] C57BL/6 Male MPTP BV Undefined DA, DOPAC, IL-1β, IL-6, TNF-α, HVA, TH,
rotational test
Ding (2013) [11] SD Male 6-OHDA EA LI4, LR3 nNOS, GFAP
Wang (2013a) [9] SD Male Rotenone EA GV16, LR3 TH, COX-2
Wang (2013b) [23] SD Male Rotenone EA GV16, LR3 TH, p-p38 MARK, COX-2
Wang (2013c) [12] SD Male Rotenone EA GV16, LR3 TH, SOD, GSH, CAT, MDA
Wang (2013d) [24] SD Male Rotenone EA GV16, LR3 UCH-L1, UBE1, Parkin, TH, α-synuclein
Ding (2012) [25] SD Male 6-OHDA EA LI4, LR3 TH, GFAP, PCNA
Huang (2012) [26] ICR Male MPTP EA GB34 Lamp 1, α-synuclein
Lu (2012) [27] C57BL/6 Male MPTP EA GV20, GV16, GB34 Locomotor counts, swimming test,
pole-climbing test
Guo (2012) [28] SD Male 6-OHDA EA GV20, GV16, GB34 GSH, SOD, MDA, GSH-Px
Yang (2011) [29] C57BL/6 Male MPTP EA PC7 Pole-climbing test, TH, DA, DOPAC, HVA
Choi (2011) [18] C57/BL6 Male MPTP MA GB34, LR3 TH, DAT, gene expression
Kim (2011) [30] C57BL/6 Male MPTP BV ST36 MAC-1, iNOS, TH
Du (2011) [31] SD Male 6-OHDA EA GV20, GV14 GABA, rotational test
Wang (2011) [32] C57BL/6 Male MPTP EA ST36, SP6 TH, DA, DOPAC, HVA, SOD, GSH, GSH-Px
Doo (2010) [33] C57BL/6 Male MPTP BV GB34 TH
Hong (2010) [34] C57BL/6 Male MPTP MA GB34 Gene expression
Jun (2010) [35] C57BL/6 Male MPTP BV BL23 TH, caspase-3, iNOS
Kim (2010) [36] C57BL/6 Male MPTP EA GB34, GB39 DA
Park (2010) [37] C57BL/6 Male MPTP BV GB39, LI11, BL23 TH, MAC-1, HSP70
Sun (2010) [38] C57BL/6 Male MPTP MA GV20, GV14 Pole-climbing test, TH, DA, DOPAC
Wang (2010a) [39] Wistar Undefined 6-OHDA EA GV16, LR3 TH, DA
Wang (2010b) [40] Wistar Undefined 6-OHDA EA GV16, LR3,CV4, ST36 GDNF
Wang (2010c) [41] C57/BL6 Male MPTP MA GV20, GV14 Pole-climbing test, TH, DA, NA, DOPAC,
5HIAA, 5HT
Yu (2010) [42] Wistar Male 6-OHDA MA GB34, LR3, ST36, SP10 Rotational test, SOD, GSH-Px, CAT, GSH, MDA
Huang (2010) [43] Wistar Male 6-OHDA EA LI4, LR3 Rotational test, BDNF, TrKB
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Table 1 Summary of acupuncture for animal PD models (Continued)
Choi (2009) [21] C57/BL6 Male MPTP MA LR3, GB34 TH, DAT
Kim (2009) [44] C57BL/6 Male MPTP BV BL23 TH, MAC-1, HSP70
Wang (2009a) [45] Wistar Male, Female 6-OHDA EA GV20, EX-NH5 TH, BDNF
Wang (2009b) [46] Wistar Male, Female 6-OHDA EA GV20, EX-NH5 TH, DAT
Kim (2008) [47] C57BL/6 Male MPTP MA GB34 TH
Guan (2008) [48] C57BL/6 Male MPTP EA GV20 Fn
Wang (2008) [49] Wistar Male, Female 6-OHDA EA GV20, EX-NH5 TH
Jeon (2008) [50] C57BL/6 Male MPTP EA GB34, SI3, BL62, ST36 Pole-climbing test, TH, DA, BDNF
Xie (2007) [51] Wistar Undefined 6-OHDA MA GV20 Rotational test, MDA, NO, SOD
Kang (2007) [52] C57BL/6 Male MPTP MA GB34, LR3 TH, COX-2, iNOS, DA, DOPAC, HVA
Huang (2007) [53] SD Male 6-OHDA MA GB34, LR3 TH
Luo (2007) [54] Wistar Male, Female 6-OHDA EA GV20, EX-NH5 NOS
Wang (2007) [55] SD Male, Female 6-OHDA MA GV20, GV16, GB34 Rotational test, DA
Jin (2006a) [56] Wistar Male, Female 6-OHDA EA Undefined GSH, GSH-Px,SOD, MDA, NOS
Jin (2006b) [57] Wistar Male, Female 6-OHDA EA Undefined DA, HVA, DOPAC
Ma (2006) [58] Wistar Male, Female 6-OHDA EA GV16, LR3 Rotational test, DA
Tang (2006) [59] C57BL/6 Male MPTP EA LI4, LR3 BDNF
Wang (2006) [60] SD Male, Female 6-OHDA EA GV16, LR6 Glutamic acid
Kim (2006) [61] C57BL/6 Male MPTP MA LR8, LR4, LR2 TH
Kim (2005) [62] SD Undefined 6-OHDA MA ST36 Rotational test, TH
Ma (2005) [63] Wistar Male, Female 6-OHDA EA GV16, LR3 Rotational test, SOD, GSH, GSH-Px
Wang (2005) [64] Wistar Undefined 6-OHDA MA GV16, LR3, CV4, ST36 TH
Park (2003) [65] SD Male 6-OHDA MA GB34, LR3, LI4, LI11 Rotational test, TH, TrkB
Liang (2002) [66] Wistar Female MFB transection EA GV14, GV21 TH, BDNF
Lin (2000) [67] SD Male, Female 6-OHDA EA LR3, SP6, ST36, GB34 DA, HVA, DOPAC
He (1998) [68] SD Male, Female 6-OHDA EA GV20, GV14 DA, NA, 5HT
Zhu (1996) [69] C57BL/6 Male MPTP MA GV20 DA, DOPAC
Abbreviations: BDNF Brain-derived neurotrophic factor, BV Bee-venom acupuncture, CAT Catalase, Caspase-3: caspase protein, COX-2 Cyclooxygenase-2, DA Dopamine, DAT Dopamine active transporter, DOPAC Dihydroxyphenyl
acetic acid, EA Electro-acupuncture, Fn Ferritin, GABA gamma-aminobutyric acid, GDNF Glial cell-derived neurotrophic factor, GFAP Glial fibrillary acidic protein, GSH Glutathione, GSHpx Glutathione peroxidase, HSP70 70 kilo Dalton
heat shock proteins, HVA Homovanillic acid, IL-1β Interleukin-1 beta, IL-6 Interleukin-6, iNOS Inducible nitric oxide synthase, Lamp 1 Lysosomal-associated membrane protein 1, MAManual acupuncture, MAC-1 Macrophage-1 antigen,
MDAMalondialdehyde, NO Nitric oxide, nNos Neuronal nitric oxide synthase, MFB Medial forebrain bundle, MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, p-p38 MARK Phospho-p38 MAPK, PCNA Proliferating cell nuclear antigen,
SD Sprague–Dawley, SOD Superoxide dismutase, TH Tyrosine hydroxylase, TNF-α Tumor necrosis factor alpha, TrkB Tropomyosin receptor kinase B, UBE1 Ubiquitin-like Modifier Activating Enzyme 1, UCH-L1 Ubiquitin C-terminal
hydrolase, 5HIAA 5-Hydroxyindoleacetic acid, 5HT 5-hydroxytryptamine, 6-OHDA 6-hydroxydopamine
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test was mainly used in conjunction with 6-OHDA (8 stud-
ies), the pole-climbing test was used in conjunction with
MPTP (6 studies), and the swimming test and locomotor
counts were each used in conjunction with MPTP
(Additional file 3). The rotational behavior test was used in
five studies with only males, four studies with a male/
female mix, and one study with animals with undefined
sex. The studies using the pole-climbing test, the swimming
test, and locomotor counts were each conducted with
males only. Of all studies including behavioral analyses,
72 % (13) of the studies used only male animals, 22 % (4)
used a male/female mix, and 6 % (1) used animals with un-
defined sex. In these studies, PD was induced using MPTP
in 53 % (9) of the studies and 6-OHDA in 47 % (8).
Evaluation of treatment effectiveness
The effectiveness of the treatment on PD was evaluated
by levels of tyrosine hydroxylase (TH), dopamine (DA),
dihydroxyphenyl acetic acid (DOPAC), homovanillic acid
(HVA), superoxide dismutase (SOD), glutathione (GSH),
and brain-derived neurotrophic factor (BDNF) (Additional
file 4). TH was the most frequently used method to deter-
mine the effectiveness of the treatment on PD (56 % [32]
of the studies). Of the studies using TH, 26 used only
males, two used a male/female mix, three used animals
with undefined sex, and one used only females. Of the
studies using DA, ten used only males, five used a male/fe-
male mix, and two used animals with undefined sex. Of
the studies using DOPAC, seven used only males, and two
used a male/female mix. Of the studies using HVA and
GSH, respectively, four of each used only males, and
two of each used a male/female mix. Of the studies
using SOD, four used only males, and two used a
male/female mix. Of the studies using BDNF, four
used only males, one used a male/female mix, and
one used only females.
Fig. 3 Sex differences according to the method used to induce PD
Fig. 2 Sex differences according to the types of animal used as PD model
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Discussion
We analyzed sex differences among previous studies that
used animal PD models of acupuncture treatment. A
total of 810 potentially relevant articles were identified,
57 of which met our inclusion criteria. C57/BL6 mice
were the most frequently used (42 %) animal PD models.
Most of the studies evaluating the effectiveness of
acupuncture treatment for PD were performed using
only male animals (67 %); only one study (2 %) was per-
formed using female animals.
Many studies have inadvertently excluded females from
animal studies of acupuncture treatment for PD. Kang
et al. suggested that acupuncture could be used as a
neuroprotective intervention for inhibiting microglial acti-
vation and inflammatory events in the MPTP-induced
male PD model [52]. Yu et al. showed that acupuncture
treatment displays antioxidative and/or neuroprotective
properties in the 6-OHDA lesioned male rat PD models
[3]. Although a few studies were performed using a male/
female mix, they could not combine and compare the re-
sults from male versus female animals. Only one report
used female animals, in which was a study in which differ-
ent frequencies of chronic EA stimulation were tested in a
partially-lesioned female rat model of PD induced by tran-
section of the MFB. This study suggested that long-term
high frequency EA is effective in halting the degeneration
of dopaminergic neurons in the substantia nigra (SN). Be-
cause the studies of male PD models generated using
MFB transection are nonexistent, we could not compare
the sex differences in this model. Taken together, there is
currently insufficient evidence from past studies to deter-
mine whether there are sex differences in the effectiveness
of acupuncture for animal PD models. In the future, stud-
ies should be performed using a male/female mix to
minimize performance bias, and ideally should include a
comparison of the sex differences.
Animal studies have often focused primarily on males.
For the most part, examination of the differences be-
tween males and females has been disregarded in
biomedical research, leaving gaps in our knowledge [42].
Recently, new drugs have been developed without con-
sidering the physiological characteristics of females or
sex differences. Women have therefore been frequently
exposed to dangerous side effects because the experi-
mental studies and clinical trials had mainly used male
subjects [70]. The lack of female participation in drug-
development studies affects males as well as females;
when side effects not seen in males during the drug
safety checks appear in females, the approval of the
drugs is delayed, and male patients waiting for the drugs
consequently suffer. The NIH requires applicants to report
their cell and animal inclusion plans as part of the preclin-
ical experimental design. Despite this NIH policy, numerous
scientific publications continue to neglect sex-based consid-
erations and analyses in preclinical and clinical research. A
stronger commitment to reporting sex-specific results will
strengthen the evidence base [13]. Fortunately, sex differ-
ences are increasingly recognized as factors that influence
the incidence and disease manifestations of all diseases, in-
cluding neurodegenerative disorders.
Some gender differences have been documented for PD
[3, 4]. Paven et al. suggested gender differences in the epi-
demiology, clinical features, treatment outcomes (medical
and surgical/deep brain stimulation), and social impact
among all available PD studies [4]. Wooten et al. performed
a meta-analysis of the differences in the incidence of PD
between men and women [3]. Smith et al. summarized evi-
dence that estrogen and selective estrogen receptor modu-
lators are neuroprotective in PD, and reviewed sex
differences in basal ganglia function and dopaminergic
pathways [71, 72]. Consistent with these past studies, if acu-
puncture research involved both males and females, add-
itional studies of acupuncture for PD would provide a more
robust conclusion about sex differences in this treatment.
Review limitations and future areas of research
A number of gaps in the reviewed literature were identified
in relation to study quality and findings. Study quality could
Fig. 4 Sex differences according to the type of acupuncture performed
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be improved by using female animal models because they
reflect the physiological characteristics of both males and
females to fully evaluate the effectiveness and safety of the
treatment for each sex, which is largely missing in the lit-
erature so far.
Conclusions
The results of our review suggest that acupuncture is an
effective treatment for animal PD models, but there is
insufficient evidence to determine whether sex differ-
ences exist in response to this treatment. Future studies
should examine the effects of acupuncture in animal PD
models of both sexes, to reflect the physiological charac-
teristics of females as well as males, and to fully evaluate
the effect and safety of this treatment.
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